Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.45
+0.84003.16%
Post-market: 27.43-0.0200-0.07%19:59 EDT
Volume:60.10M
Turnover:1.65B
Market Cap:156.07B
PE:20.18
High:27.76
Open:26.82
Low:26.82
Close:26.61
52wk High:27.94
52wk Low:20.92
Shares:5.69B
Float Shares:5.68B
Volume Ratio:1.63
T/O Rate:1.06%
Dividend:1.72
Dividend Rate:6.26%
EPS(TTM):1.36
EPS(LYR):1.36
ROE:8.89%
ROA:5.68%
PB:1.80
PE(LYR):20.12

Loading ...

Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 28, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 18, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 17, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 17, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 17, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 01, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 01, 2020

Major Issues Report

8-K - Current report
May 28, 2020

Major Issues Report

8-K - Current report
May 22, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 19, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 30, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Apr 28, 2020

Major Issues Report

8-K - Current report
Apr 24, 2020

Major Issues Report

Current report, item 5.07